Table 1 Baseline characteristics of the reported cohort and enrolment bias.
MRI (N = 158) | No MRI (N = 532) | p-value | |
|---|---|---|---|
Age, years | 68 [54, 77] | 63 [50, 76] | 0.05 |
Female | 71 (45) | 244 (47) | 0.6 |
White | 51 (32) | 148 (29) | 0.4 |
Presumed etiology | <0.01 | ||
Hypertensive | 78 (49) | 241 (48) | |
Amyloid | 59 (37) | 62 (12) | |
Coagulopathy* | 16 (10) | 86 (17) | |
Other | 5 (3) | 121 (24) | |
GCS at admission | 14 [9, 15] | 10 [5, 15] | <0.01 |
ICH characteristics on admission CT | |||
Lobar | 56 (35) | 110 (21) | <0.01 |
Deep | 62 (39) | 240 (47) | 0.1 |
Infratentorial | 28 (18) | 74 (15) | 0.2 |
ICH volume | <0.01 | ||
<30 | 121 (78) | 306 (66) | |
30–60 | 27 (17) | 89 (19) | |
>60 | 7 (5) | 69 (15) | |
IVH | 72 (47) | 281 (59)** | <0.01 |
ICH prognostic scores | |||
ICH score | 1 [1, 2] | 2 [1, 3] | <0.01 |
FUNC score | 9 [7, 10] | 8 [6, 9] | <0.01 |
Hospital course | |||
EVD | 31 (20) | 142 (27) | 0.05 |
Clot evacuation | 16 (10) | 69 (13) | 0.3 |
ICU stay, days | 4 [2, 8] | 4 [2, 9] | 0.06 |
Hospital stay, days | 10 [6, 20] | 8 [5, 19] | 0.05 |
Outcome 3 months | |||
GOS | 3 [2, 4] | 3 [2, 5] | <0.01 |
Dead | 24 (22) | 158 (42)** | <0.01 |
